“…It is used as a diagnostic biomarker to differentiate squamous lung cancer and adenocarcinoma of lung (Tsuta et al, 2011). Expression of DSC3 protein is known in squamous non-small cell lung carcinoma (NSCLC), melanoma, ovarian cancer, bladder cancer, pancreatic cancer, esophageal cancer, cervical cancer, chondrosarcoma, oral cancer and colorectal cancer (Valentina et al, 2009, Khamar 2017, Salerno et al, 2016, Uhlen et al, 2010, Uhlen et al, 2017, Robertson et al,2017, Wang et al,2014, Fitzgerald et al,2011, Wang et al, 2011, Knösel et al,2013. Its prognostic value is perplexing with better prognosis in squamous NSCLC (Belani et al,2017, Cui et al,2012 and poor prognosis in ovarian cancer.…”